Class IC Antidysrhythmic Agents

Encainide and flecainide are prototypical class IC agents. They have no effect on the duration of the action potential or the refractory period. They cause marked depression of automaticity (phase 4) of pacemaker cells and slow conduction velocity (phase 0). These agents are not used in the Ed setting because of associated prodysrhythmic effects. They were earlier thought helpful for the treatment of atrial fibrillation and refractory VT. However, the Cardiac Arrhythmia Suppression Trial (CAST) demonstrated an increased mortality associated with class IC agents when used to suppress ventricular ectopy in patients with a history of a recent MI and LV dysfunction.2 In fact, encainide was voluntarily taken off the market because of its prodysrhythmic tendencies. It is available only on a limited basis.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook

Post a comment